Page last updated: 2024-10-17

n(g),n(g')-dimethyl-l-arginine and Metabolic Diseases

n(g),n(g')-dimethyl-l-arginine has been researched along with Metabolic Diseases in 4 studies

N,N-dimethylarginine: asymmetric dimethylarginine; do not confuse with N,N'-dimethylarginine

Metabolic Diseases: Generic term for diseases caused by an abnormal metabolic process. It can be congenital due to inherited enzyme abnormality (METABOLISM, INBORN ERRORS) or acquired due to disease of an endocrine organ or failure of a metabolically important organ such as the liver. (Stedman, 26th ed)

Research Excerpts

ExcerptRelevanceReference
"Rosiglitazone (4 mg/d for 4 weeks and then 4 mg twice daily for 8 weeks), an insulin-sensitizing agent, was given to 7 insulin-resistant subjects with hypertension."3.71Relationship between insulin resistance and an endogenous nitric oxide synthase inhibitor. ( Abbasi, F; Chu, JW; Cooke, JP; Lamendola, C; McLaughlin, TL; Reaven, GM; Stühlinger, MC; Tsao, PS, 2002)
"Low and high birth weights have been linked to increased susceptibility to cardiovascular and metabolic alterations."2.50Is asymmetric dimethylarginine associated with being born small and large for gestational age? ( Chiarelli, F; Chiavaroli, V; de Giorgis, T; Diesse, L; Giannini, C; Marcovecchio, ML; Mohn, A, 2014)

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (50.00)29.6817
2010's2 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chiavaroli, V1
Diesse, L1
de Giorgis, T1
Giannini, C1
Marcovecchio, ML1
Chiarelli, F1
Mohn, A1
Siervo, M1
Corander, M1
Stranges, S1
Bluck, L1
Eid, HM1
Arnesen, H1
Hjerkinn, EM1
Lyberg, T1
Seljeflot, I1
Stühlinger, MC1
Abbasi, F1
Chu, JW1
Lamendola, C1
McLaughlin, TL1
Cooke, JP1
Reaven, GM1
Tsao, PS1

Reviews

2 reviews available for n(g),n(g')-dimethyl-l-arginine and Metabolic Diseases

ArticleYear
Is asymmetric dimethylarginine associated with being born small and large for gestational age?
    Antioxidants & redox signaling, 2014, May-20, Volume: 20, Issue:15

    Topics: Arginine; Biomarkers; Birth Weight; Cardiovascular Diseases; Female; Gestational Age; Humans; Metabo

2014
Post-challenge hyperglycaemia, nitric oxide production and endothelial dysfunction: the putative role of asymmetric dimethylarginine (ADMA).
    Nutrition, metabolism, and cardiovascular diseases : NMCD, 2011, Volume: 21, Issue:1

    Topics: Animals; Arginine; Diabetes Mellitus, Type 2; Endothelium, Vascular; Glucose; Glucose Tolerance Test

2011

Other Studies

2 other studies available for n(g),n(g')-dimethyl-l-arginine and Metabolic Diseases

ArticleYear
Relationship between obesity, smoking, and the endogenous nitric oxide synthase inhibitor, asymmetric dimethylarginine.
    Metabolism: clinical and experimental, 2004, Volume: 53, Issue:12

    Topics: Aged; Arginine; Arteriosclerosis; Coronary Disease; Cross-Sectional Studies; Enzyme Inhibitors; Huma

2004
Relationship between insulin resistance and an endogenous nitric oxide synthase inhibitor.
    JAMA, 2002, Mar-20, Volume: 287, Issue:11

    Topics: Adult; Aged; Arginine; Cardiovascular Diseases; Cross-Sectional Studies; Enzyme Inhibitors; Female;

2002